Pharmaceuticals
2025Fiscal year
Companies 155
Median of average pay per registered director · KRW 282 million
| Company | Notes | ||||
|---|---|---|---|---|---|
| April Bio | KRW 360 million | KRW 282 million | 2 | 12 | |
| Orum Therapeutics | KRW 174 million | KRW 455 million | 3 | 21 | |
| Ligachem Biosciences | KRW 157 million | KRW 194 million | 5 | 180 | |
| Vi Gen Cell | KRW 155 million | KRW 197 million | 3 | 43 | |
| Chongkundang Holdings | KRW 142 million | KRW 301 million | 2 | 38 | Denominator mismatch flagged |
| Qurient | KRW 139 million | KRW 190 million | 6 | 32 | |
| G2 Gbio | KRW 125 million | KRW 238 million | 4 | 48 | |
| SK Biopharmaceuticals | KRW 121 million | KRW 663 million | 3 | 272 | Filer note attached |
| Immuneoncia Therapeutics | KRW 115 million | KRW 344 million | 2 | 22 | |
| Samsung Biologics | KRW 112 million | KRW 2,831 million | 3 | 5,455 | |
| Yuhan | KRW 109 million | KRW 684 million | 3 | 1,566 | |
| Voronoi | KRW 104 million | KRW 137 million | 3 | 72 | |
| Celltrion | KRW 102 million | KRW 1,466 million | 4 | 3,153 | |
| Penetrium Bio | KRW 97 million | KRW 94 million | 6 | 29 | |
| Daewon Pharmaceutical | KRW 86 million | KRW 542 million | 3 | 1,349 | |
| Hanmi Pharm | KRW 86 million | KRW 408 million | 6 | 2,382 | |
| Ilyang Pharmaceutical | KRW 85 million | KRW 259 million | 3 | 665 | |
| Curacle | KRW 84 million | KRW 198 million | 4 | 31 | |
| Myungin Pharm | KRW 83 million | KRW 436 million | 3 | 440 | |
| HK Inno.N | KRW 83 million | KRW 1,059 million | 3 | 1,723 | |
| Hanall Biopharma | KRW 82 million | KRW 352 million | 4 | 315 | |
| Samjin Pharmaceutical | KRW 82 million | KRW 1,518 million | 5 | 819 | Filer note attached |
| Kwangdong Pharmaceutical | KRW 81 million | KRW 591 million | 3 | 798 | |
| Chong Kun Dang | KRW 81 million | KRW 282 million | 5 | 2,304 | Filer note attached |
| Onconic Therapeutics | KRW 79 million | KRW 447 million | 2 | 14 | |
| Donga ST | KRW 79 million | KRW 570 million | 3 | 1,685 | |
| GC | KRW 78 million | KRW 1,361 million | 3 | 163 | |
| Inventera | KRW 78 million | KRW 342 million | 2 | 18 | |
| Ildong Pharm | KRW 78 million | KRW 366 million | 4 | 1,104 | |
| Handok | KRW 78 million | KRW 396 million | 5 | 951 | |
| Daewoong Pharmaceutical | KRW 78 million | KRW 558 million | 3 | 1,794 | |
| Celltrion Pharm | KRW 77 million | KRW 442 million | 3 | 1,006 | |
| Shinpoong Pharmaceutical | KRW 77 million | KRW 170 million | 2 | 792 | |
| Aribio Lab | KRW 77 million | KRW 73 million | 3 | 14 | |
| Korea Pharma | KRW 76 million | KRW 337 million | 3 | 186 | |
| Reyon Pharmaceutical | KRW 76 million | KRW 457 million | 2 | 457 | |
| Sillajen | KRW 76 million | KRW 178 million | 2 | 56 | |
| Whanin Pharm | KRW 75 million | KRW 734 million | 2 | 671 | |
| JW Shinyak | KRW 75 million | KRW 181 million | 2 | 173 | |
| Samsung Pharmaceutical | KRW 75 million | KRW 146 million | 4 | 50 | |
| GC Well Being | KRW 75 million | KRW 198 million | 4 | 242 | Denominator mismatch flagged |
| Kyongbo Pharmaceutical | KRW 75 million | KRW 281 million | 3 | 571 | |
| Parataxis Korea | KRW 75 million | KRW 166 million | 3 | 16 | |
| Pharm Gen Science | KRW 74 million | KRW 367 million | 6 | 229 | |
| Kainos Medicine | KRW 74 million | KRW 164 million | 2 | 15 | |
| Jeil Pharma Holdings | KRW 73 million | KRW 222 million | 4 | 40 | |
| GC Biopharma | KRW 73 million | KRW 649 million | 3 | 2,351 | |
| Boryung | KRW 72 million | KRW 1,429 million | 4 | 1,645 | Filer note attached |
| Hyundai Pharm | KRW 72 million | KRW 438 million | 1 | 399 | Fiscal year end 11 |
| Dongwha Pharm | KRW 72 million | KRW 297 million | 4 | 838 | |
| Bukwang Pharmaceutical | KRW 71 million | KRW 357 million | 2 | 432 | Filer note attached |
| Shaperon | KRW 71 million | KRW 406 million | 1 | 53 | |
| JW Lifescience | KRW 70 million | KRW 172 million | 1 | 319 | |
| MFC | KRW 70 million | KRW 281 million | 3 | 49 | |
| Aminologics | KRW 69 million | KRW 100 million | 4 | 41 | |
| Yungjin Pharm | KRW 69 million | KRW 659 million | 2 | 626 | |
| Daewoong | KRW 69 million | KRW 187 million | 2 | 413 | |
| Kukjeon | KRW 69 million | KRW 291 million | 3 | 172 | |
| Huons Global | KRW 68 million | KRW 383 million | 3 | 70 | |
| Kukje Pharma | KRW 68 million | KRW 2,112 million | 3 | 272 | |
| CKD Bio | KRW 68 million | KRW 112 million | 3 | 533 | |
| Dong Kook Pharmaceutical | KRW 68 million | KRW 711 million | 2 | 1,306 | |
| Samil Pharmaceutical | KRW 68 million | KRW 497 million | 4 | 614 | |
| ST Pharm | KRW 68 million | KRW 334 million | 2 | 780 | |
| SK Bioscience | KRW 68 million | KRW 1,084 million | 3 | 1,129 | |
| Korea United Pharm | KRW 67 million | KRW 836 million | 5 | 902 | |
| Green Lifescience | KRW 66 million | KRW 132 million | 2 | 63 | |
| SAM Chun Dang Pharm | KRW 66 million | KRW 66 million | 5 | 436 | |
| Seoul Pharma | KRW 66 million | KRW 57 million | 4 | 132 | |
| Metacare | KRW 66 million | KRW 49 million | 3 | 32 | |
| Jeil Pharm | KRW 64 million | KRW 302 million | 5 | 1,011 | |
| Huons | KRW 64 million | KRW 279 million | 5 | 661 | |
| JW Pharmaceutical | KRW 64 million | KRW 544 million | 3 | 1,106 | |
| IM Biologics | KRW 63 million | KRW 159 million | 4 | 41 | |
| Myung Moon Pharm | KRW 63 million | KRW 651 million | 2 | 309 | |
| Samik Pharm | KRW 63 million | KRW 242 million | 4 | 72 | |
| CMG Pharmaceutical | KRW 63 million | KRW 93 million | 4 | 206 | |
| Choa Pharmaceutical | KRW 62 million | KRW 452 million | 3 | 243 | |
| Daehan Nupharm | KRW 62 million | KRW 712 million | 2 | 393 | |
| Ildong Holdings | KRW 62 million | KRW 572 million | 4 | 84 | |
| Yuyu Pharma | KRW 62 million | KRW 581 million | 2 | 248 | |
| Suheung | KRW 62 million | KRW 406 million | 3 | 773 | |
| Daihan Pharmaceutical | KRW 62 million | KRW 257 million | 3 | 737 | |
| Oscotec | KRW 62 million | KRW 476 million | 3 | 57 | |
| Hwail Pharm | KRW 62 million | KRW 212 million | 3 | 145 | |
| Dong Koo Bio & Pharma | KRW 62 million | KRW 436 million | 4 | 271 | |
| Sinsin Pharmaceutical | KRW 61 million | KRW 372 million | 2 | 369 | |
| Kolon Life Science | KRW 61 million | KRW 590 million | 3 | 454 | Filer note attached |
| Inventage Lab | KRW 61 million | KRW 266 million | 5 | 73 | |
| IT-Chem | KRW 61 million | KRW 103 million | 3 | 105 | |
| HLB Pharmaceutical | KRW 60 million | KRW 132 million | 4 | 93 | |
| Komipharm International | KRW 60 million | KRW 154 million | 4 | 82 | |
| ISU Abxis | KRW 60 million | KRW 342 million | 3 | 190 | |
| High Tech Pharm | KRW 60 million | KRW 233 million | 3 | 130 | |
| Optipharm | KRW 60 million | KRW 175 million | 2 | 79 | |
| Genome & Company | KRW 60 million | KRW 189 million | 4 | 96 | Filer note attached |
| Ahn-Gook Pharmaceutical | KRW 59 million | KRW 695 million | 3 | 424 | |
| C&R Research | KRW 58 million | KRW 365 million | 3 | 522 | Filer note attached |
| JIN Yang Pharmacetical | KRW 58 million | KRW 382 million | 3 | 219 | |
| Medpacto | KRW 58 million | KRW 175 million | 4 | 54 | |
| Tium Bio | KRW 58 million | KRW 267 million | 3 | 67 | |
| EN Cell | KRW 57 million | KRW 286 million | 3 | 112 | |
| Choong ANG Vaccine Laboratory | KRW 57 million | KRW 262 million | 4 | 194 | |
| Humedix | KRW 57 million | KRW 217 million | 4 | 377 | |
| WSI | KRW 56 million | KRW 633 million | 3 | 18 | Holding-like flagged |
| Kyungdong Pharm | KRW 56 million | KRW 472 million | 3 | 363 | |
| Sam-A Pharm | KRW 56 million | KRW 299 million | 2 | 310 | |
| Korean Drug | KRW 56 million | KRW 348 million | 3 | 238 | |
| Telcon RF Pharmaceutical | KRW 56 million | KRW 88 million | 5 | 133 | |
| Kanaph Therapeutics | KRW 55 million | KRW 203 million | 3 | 23 | |
| Dream CIS | KRW 55 million | KRW 179 million | 4 | 395 | Filer note attached |
| Vaxcell-Bio Therapeutics | KRW 55 million | KRW 212 million | 2 | 91 | |
| Abion | KRW 55 million | KRW 189 million | 4 | 34 | Filer note attached |
| Woo Gene B&G | KRW 54 million | KRW 253 million | 2 | 103 | |
| Kyung NAM Pharm | KRW 54 million | KRW 45 million | 4 | 238 | |
| Optus Pharmaceutical | KRW 54 million | KRW 188 million | 2 | 250 | Filer note attached |
| Daebongls | KRW 54 million | KRW 189 million | 3 | 138 | |
| Future Chem | KRW 53 million | KRW 139 million | 4 | 94 | |
| Korea Arlico Pharm | KRW 53 million | KRW 371 million | 2 | 228 | |
| Hana Pharm | KRW 53 million | KRW 283 million | 4 | 706 | |
| Withus Pharmaceutical | KRW 53 million | KRW 281 million | 3 | 220 | |
| Ilsung IS | KRW 52 million | KRW 317 million | 5 | 194 | |
| Olipass | KRW 52 million | KRW 91 million | 4 | 26 | |
| Polaris AI Pharma | KRW 51 million | KRW 434 million | 4 | 167 | |
| Cellbion | KRW 51 million | KRW 157 million | 2 | 56 | |
| Theragen Etex | KRW 51 million | KRW 194 million | 5 | 222 | |
| Aprogen | KRW 50 million | KRW 175 million | 2 | 311 | |
| Shinil Pharmaceutical | KRW 50 million | KRW 339 million | 3 | 413 | |
| Binex | KRW 49 million | KRW 358 million | 3 | 791 | |
| HLB Therapeutics | KRW 49 million | KRW 70 million | 3 | 50 | |
| Enzychem Lifesciences | KRW 49 million | KRW 766 million | 3 | 116 | |
| Eagle Veterinary Technology | KRW 48 million | KRW 112 million | 2 | 110 | |
| DAE HWA Pharm | KRW 48 million | KRW 548 million | 1 | 369 | Filer note attached |
| Vivozon Pharmaceutical | KRW 47 million | KRW 126 million | 2 | 104 | |
| Aprogen Biologics | KRW 47 million | KRW 227 million | 3 | 445 | |
| CTC BIO | KRW 47 million | KRW 340 million | 5 | 237 | Filer note attached |
| GL Pharm Tech | KRW 46 million | KRW 95 million | 2 | 32 | |
| Adbiotech | KRW 46 million | KRW 76 million | 4 | 38 | Denominator mismatch flagged |
| Duchem Bio | KRW 45 million | KRW 114 million | 2 | 115 | |
| MOA Life Plus | KRW 45 million | KRW 180 million | 4 | 32 | |
| Gene Bio Tech | KRW 45 million | KRW 83 million | 3 | 45 | |
| Daesung Microbiological Labs | KRW 45 million | KRW 203 million | 2 | 138 | |
| Dongsung Pharmaceutical | KRW 43 million | KRW 167 million | 3 | 307 | |
| Aptocrom | KRW 43 million | KRW 395 million | 3 | 16 | Denominator mismatch flagged |
| RP Bio | KRW 41 million | KRW 155 million | 3 | 250 | |
| Cellromax Science | KRW 41 million | KRW 304 million | 3 | 52 | |
| BC World Pharm | KRW 41 million | KRW 325 million | 3 | 288 | |
| Union Korea Pharm | KRW 39 million | KRW 59 million | 4 | 123 | |
| SLS Bio | KRW 37 million | KRW 67 million | 3 | 25 | |
| Prestige Biologics | KRW 37 million | KRW 97 million | 4 | 279 | Denominator mismatch flagged · Fiscal year end 06 |
| Anterogen | KRW 34 million | KRW 207 million | 3 | 16 | |
| TDS Pharm | KRW 32 million | KRW 306 million | 2 | 111 | |
| Into Cell | Value not displayed | KRW 204 million | 3 | — | |
| Prestige Biopharma Limited KDR | Foreign-incorporated listing | Foreign-incorporated listing | 3 | 67 | Filer note attached · Fiscal year end 06 |
| Neo Immune Tech | Foreign-incorporated listing | Foreign-incorporated listing | 1 | 40 | Filer note attached · Denominator mismatch flagged |
Before reading this table
- Figures collect the filed per-person averages without transformation, and can differ from totals divided by headcounts.
- Listed filers only, and consolidated subsidiaries' staff are not included.
- These are filed values whose accuracy the source institution does not guarantee.
- Company rows reproduce each filer's own reported values without transformation, and this site computes none of them.
- Where few registered directors are covered, the per-person average approaches a few individuals' pay.
- Sharing an industry code does not mean doing the same work.
- Filed values on the wrong digit scale are converted to a common basis against the company's own filings in other years, and where no basis exists the reason shows instead of an amount.
- Classifications with thin samples publish no median or weighted industry figure, while the employee average is shown regardless of sample size alongside the company count.
Industry groupings and names follow Naver Finance's sector classification. The per-company figures themselves reproduce annual-report filings.